News FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns September 26, 2024 Read More » COBENFY September 26, 2024 Read More » AQNEURSA September 25, 2024 Read More » MIPLYFFA™ September 20, 2024 Read More » Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination September 17, 2024 Read More » OCREVUS ZUNOVO September 13, 2024 Read More » EBGLYSS September 13, 2024 Read More » ENZEEVU September 12, 2024 Read More » TECENTRIQ HYBREZA September 12, 2024 Read More » Page1 Page2 Page3 Page4 Page5 Page6 … Page42 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
FDA is Alerting Patients and Health Care Professionals About the Voluntary Withdrawal of Oxbryta from the Market Due to Safety Concerns September 26, 2024 Read More »
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone OralSuspension Due to Bacterial Contamination September 17, 2024 Read More »